FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099685316> ?p ?o ?g. }

• W2099685316 endingPage "2844" @default.
• W2099685316 startingPage "2838" @default.
• W2099685316 abstract "ABSTRACT Endogenous peptide antibiotics are under investigation as inhaled therapeutic agents for cystic fibrosis (CF) lung disease. The bactericidal activities of five cathelicidin peptides (LL37 [human], CAP18 [rabbit], mCRAMP [mouse], rCRAMP [rat], and SMAP29 [sheep]), three novel alpha-helical peptides derived from SMAP29 and termed ovispirins (OV-1, OV-2, and OV-3), and two derivatives of CAP18 were tested by broth microdilution assays. Their MICs were determined for multiply antibiotic-resistant Pseudomonas aeruginosa ( n = 24), Burkholderia cepacia ( n = 5), Achromobacter xylosoxidans ( n = 5), and Stenotrophomonas maltophilia ( n = 5) strains isolated from CF patients. SMAP29 was most active and inhibited mucoid and nonmucoid P. aeruginosa strains (MIC, 0.06 to 8 μg/ml). OV-1, OV-2, and OV-3 were nearly as active (MIC, 0.03 to 16 μg/ml), but CAP18 (MIC, 1.0 to 32 μg/ml), CAP18-18 (MIC, 1.0 to >32 μg/ml), and CAP18-22 (MIC, 0.5 to 32 μg/ml) had variable activities. LL37, mCRAMP, and rCRAMP were least active against the clinical isolates studied (MIC, 1.0 to >32 μg/ml). Peptides had modest activities against S. maltophilia and A. xylosoxidans (MIC range, 1.0 to > 32 μg/ml), but none inhibited B. cepacia . However, CF sputum inhibited the activity of SMAP29 substantially. The effects of peptides on bacterial cell membranes and eukaryotic cells were examined by scanning electron microscopy and by measuring transepithelial cell resistance, respectively. SMAP29 caused the appearance of bacterial membrane blebs within 1 min, killed P. aeruginosa within 1 h, and caused a dose-dependent, reversible decrease in transepithelial resistance within 5 h. The tested cathelicidin-derived peptides represent a novel class of antimicrobial agents and warrant further development as prophylactic or therapeutic agents for CF lung disease." @default.
• W2099685316 created "2016-06-24" @default.
• W2099685316 creator A5001665873 @default.
• W2099685316 creator A5007307330 @default.
• W2099685316 creator A5024177817 @default.
• W2099685316 creator A5041740229 @default.
• W2099685316 creator A5048682080 @default.
• W2099685316 creator A5050473740 @default.
• W2099685316 creator A5062808338 @default.
• W2099685316 creator A5085725734 @default.
• W2099685316 date "2001-10-01" @default.
• W2099685316 modified "2023-10-16" @default.
• W2099685316 title "Cathelicidin Peptides Inhibit Multiply Antibiotic-Resistant Pathogens from Patients with Cystic Fibrosis" @default.
• W2099685316 cites W1506470251 @default.
• W2099685316 cites W1834101661 @default.
• W2099685316 cites W1968087305 @default.
• W2099685316 cites W1976301815 @default.
• W2099685316 cites W1981854518 @default.
• W2099685316 cites W1993513102 @default.
• W2099685316 cites W1998026083 @default.
• W2099685316 cites W2010980975 @default.
• W2099685316 cites W2023192638 @default.
• W2099685316 cites W2027585104 @default.
• W2099685316 cites W2034280103 @default.
• W2099685316 cites W2036090704 @default.
• W2099685316 cites W2038717313 @default.
• W2099685316 cites W2044373024 @default.
• W2099685316 cites W2050242176 @default.
• W2099685316 cites W2051142131 @default.
• W2099685316 cites W2061909665 @default.
• W2099685316 cites W2066432956 @default.
• W2099685316 cites W2077756665 @default.
• W2099685316 cites W2080752203 @default.
• W2099685316 cites W2087765037 @default.
• W2099685316 cites W2088707861 @default.
• W2099685316 cites W2096283909 @default.
• W2099685316 cites W2101419887 @default.
• W2099685316 cites W2109399497 @default.
• W2099685316 cites W2140313585 @default.
• W2099685316 cites W2141098072 @default.
• W2099685316 cites W2142443730 @default.
• W2099685316 cites W2144440398 @default.
• W2099685316 cites W2147668388 @default.
• W2099685316 cites W2160248841 @default.
• W2099685316 cites W2161781239 @default.
• W2099685316 cites W2326999967 @default.
• W2099685316 cites W4213354399 @default.
• W2099685316 cites W4252831606 @default.
• W2099685316 cites W4255507877 @default.
• W2099685316 doi "https://doi.org/10.1128/aac.45.10.2838-2844.2001" @default.
• W2099685316 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/90740" @default.
• W2099685316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11557478" @default.
• W2099685316 hasPublicationYear "2001" @default.
• W2099685316 type Work @default.
• W2099685316 sameAs 2099685316 @default.
• W2099685316 citedByCount "126" @default.
• W2099685316 countsByYear W20996853162012 @default.
• W2099685316 countsByYear W20996853162013 @default.
• W2099685316 countsByYear W20996853162014 @default.
• W2099685316 countsByYear W20996853162015 @default.
• W2099685316 countsByYear W20996853162016 @default.
• W2099685316 countsByYear W20996853162017 @default.
• W2099685316 countsByYear W20996853162018 @default.
• W2099685316 countsByYear W20996853162019 @default.
• W2099685316 countsByYear W20996853162020 @default.
• W2099685316 countsByYear W20996853162021 @default.
• W2099685316 countsByYear W20996853162022 @default.
• W2099685316 countsByYear W20996853162023 @default.
• W2099685316 crossrefType "journal-article" @default.
• W2099685316 hasAuthorship W2099685316A5001665873 @default.
• W2099685316 hasAuthorship W2099685316A5007307330 @default.
• W2099685316 hasAuthorship W2099685316A5024177817 @default.
• W2099685316 hasAuthorship W2099685316A5041740229 @default.
• W2099685316 hasAuthorship W2099685316A5048682080 @default.
• W2099685316 hasAuthorship W2099685316A5050473740 @default.
• W2099685316 hasAuthorship W2099685316A5062808338 @default.
• W2099685316 hasAuthorship W2099685316A5085725734 @default.
• W2099685316 hasBestOaLocation W20996853162 @default.
• W2099685316 hasConcept C176947019 @default.
• W2099685316 hasConcept C2776352461 @default.
• W2099685316 hasConcept C2776938444 @default.
• W2099685316 hasConcept C2777181619 @default.
• W2099685316 hasConcept C2777379352 @default.
• W2099685316 hasConcept C2777637488 @default.
• W2099685316 hasConcept C2780855054 @default.
• W2099685316 hasConcept C2780950330 @default.
• W2099685316 hasConcept C3019249092 @default.
• W2099685316 hasConcept C4937899 @default.
• W2099685316 hasConcept C501593827 @default.
• W2099685316 hasConcept C523546767 @default.
• W2099685316 hasConcept C540938839 @default.
• W2099685316 hasConcept C54355233 @default.
• W2099685316 hasConcept C86803240 @default.
• W2099685316 hasConcept C89423630 @default.
• W2099685316 hasConceptScore W2099685316C176947019 @default.
• W2099685316 hasConceptScore W2099685316C2776352461 @default.
• W2099685316 hasConceptScore W2099685316C2776938444 @default.
• W2099685316 hasConceptScore W2099685316C2777181619 @default.

• next